导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 31.42% | 127/1050 |
| 近一周 | -2.39% | 587/1104 |
| 近一月 | -5.50% | 657/1102 |
| 近一季 | -16.35% | 879/1092 |
| 近半年 | 25.65% | 100/1070 |
| 近一年 | 45.68% | 91/1018 |
| 近两年 | 212.83% | 46/926 |
| 近三年 | 159.17% | 51/834 |
| 成立以来 | 43.21% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.02% 415/1070 |
78.01% 116/1101 |
- - |
- - |
| 2025 | 71.54% 57/1065 |
-2.24% 922/1014 |
6.63% 209/1038 |
57.92% 46/1050 |
4.21% 167/1065 |
| 2024 | 19.96% 91/1011 |
-2.52% 449/960 |
-2.59% 472/983 |
11.63% 489/991 |
13.17% 42/1011 |
| 2023 | -13.09% 436/952 |
9.03% 142/880 |
0.95% 137/895 |
-16.35% 808/915 |
-5.59% 569/952 |
| 2022 | -24.48% 476/867 |
-13.76% 210/773 |
4.29% 561/806 |
-16.88% 679/845 |
1.02% 382/867 |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 泰康研究精选股票发起A VS. 东吴新产业精选股票A(580008) |